CoreWeave acquired a portion of the Northeast Science and Technology Center in Kenilworth, New Jersey, from Onyx Equities and ...

Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed ...

This week, Merck filed a notice in accordance with New Jersey's WARN Act, indicating it plans to eliminate 58 positions at ...

In a shakeup for the sprawling 102-acre campus in Kenilworth, CoreWeave has purchased a data center site at NEST for $322 ...

Note to Editors: Merck & Co., Inc., Kenilworth, NJ, USA, is known as MSD outside of the US and Canada. Media Contact: MSD Neren Rau Director: Policy and Communications +27116553028 ...

The joint venture acquiror of Merck’s former headquarters is detailing more of its plans to bring a new life sciences and biotechnology hub to the 108-acre Kenilworth campus.

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win technology, has entered into a collaborative agreement ...

Merck has reached a deal with real estate business Onyx Equities to sell its 108-acre campus in Kenilworth, New Jersey, where the drug behemoth relocated its main digs back in 2015.